Results 111 to 120 of about 2,461 (207)

Preparation and Evaluation of Nano-vesicles of Brimonidine Tartrate as an Ocular Drug Delivery System [PDF]

open access: yes
The objective of the present investigation was to design a vesicular formulation of brimonidine tartrate and evaluate its ability to reduce the dosing frequency and improve the therapeutic efficacy of the drug.
Aggarwal   +16 more
core   +2 more sources

PREPARATION AND EVALUATION OF NIOSOMES OF BRIMONIDINE TARTRATE AS OCULAR DRUG DELIVERY SYSTEM [PDF]

open access: yes, 2013
Nioosomes of brimonidine tartrate were prepared by film hydration method. The prepared vesicles were evaluated for photomicroscopic characteristics, entrapment efficiency, in vitro, ex- in vitro drug release, in vivo intra ocular pressure lowering ...
,HARISH,GANESH,CHARYULU,SATYNARAYANA, P. PRABHU, MARINA KOLAND, K.VIJAYNARAYAN
core   +1 more source

Systematic Review of Randomized Clinical Trials on Safety and Efficacy of Pharmacological and Nonpharmacological Treatments for Retinitis Pigmentosa

open access: yesJournal of Ophthalmology, 2015
Aims. Several treatments have been proposed to slow down progression of Retinitis pigmentosa (RP), a hereditary retinal degenerative condition leading to severe visual impairment.
Marta Sacchetti   +3 more
doaj   +1 more source

Effect of over-the-counter brimonidine tartrate 0.025% ophthalmic solution on pupil size in healthy adults. [PDF]

open access: yesGraefes Arch Clin Exp Ophthalmol, 2021
Nejad M   +5 more
europepmc   +1 more source

The Effect of Glaucoma Medication on Choroidal Thickness Measured with Enhanced Depth-Imaging Optical Coherence Tomography [PDF]

open access: yes, 2019
The aim of this study was to examine the effect of the glaucoma medication on Choroidal Thickness (CT) in those with Primary Open-Angle Glaucoma (POAG) and normal cases.
BAYRAKTAR, Serife   +3 more
core   +4 more sources

Pharmacodynamic approach for proving equivalence of two ophtalmic solutions containing Brimonidine Tartarate 0.2% in healthy volunteers [PDF]

open access: yesHospital Pharmacology, 2018
Introduction: Bromonidine tartarate ophthalmic solution (CAS registry-number: 70359- 46-5) is a relatively selective alpha-2 adrenergic agonist, indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular ...
Hristova-Valcheva Ruska   +6 more
doaj  

Fluorimetric quantification of brimonidine tartrate in eye drops.

open access: yesIndian journal of pharmaceutical sciences, 2014
A simple and sensitive spectrofluorimetric method has been developed for the estimation of brimonidine tartrate in pure and eye drops. Linearity was obeyed in the range of 0.2-3.0 ΅g/ml in dimethyl formamide as solvent at an emission wavelength (λem) of 530 nm after excitation wavelength (λex) of 389 nm with good correlation coefficient of 0.998.
Sunitha, G   +5 more
openaire   +1 more source

Comparative analysis of PLGA ocuserts of brimonidine tartrate prepared with different methods

open access: yesEuropean Pharmaceutical Journal
The eye is a highly sensitive organ with multiple physiological barriers that limit drug bioavailability and reduce patient compliance. Research studies are still going on to discover a novel drug delivery system for ocular delivery. The current research
Paramjot   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy